News | February 10, 2014

Congresswomen Highlights Breast Cancer Detection Bill During Visit to Mammography Vendor

Kuster's Breast Density and Mammography Report Act to promote breast cancer detection, prevention

Breast Density and Mammography Reporting Act Kuster Women's Health
February 10, 2014 — Congresswoman Annie Kuster (NH-02) met Jan. 21 with executives from Gamma Medica to discuss the Breast Density and Mammography Reporting Act. Kuster recently cosponsored the bill in an effort to promote better breast cancer detection and prevention, and to help provide women with the tools to make informed health decisions.
“Thousands of women in New Hampshire and across the country are being diagnosed with breast cancer each year. It’s absolutely essential they have every tool available to battle this terrible disease,” Kuster said. “That’s what the Breast Density and Mammography Reporting Act is all about. It will help to make sure women, especially those at greater risk for breast cancer, can detect it early and return to good health.”
First introduced by Congresswoman Rosa DeLauro, the bill ensures that relative breast density is included in the information provided to women and health care providers following a mammogram. Studies have shown that women with dense breast tissue are at least four times more likely to develop breast cancer, and they are also more likely to have an inaccurate mammogram reading.
Gamma Medica develops, markets and services molecular breast imaging systems to help radiologists detect early stage cancers. The company utilizes molecular breast imaging, a secondary diagnostic tool that enables and improves assessments, especially for women with dense breast tissue.
In 2013, an estimated 1,180 Granite State women were projected to be newly diagnosed with breast cancer, according to the New Hampshire Breast Cancer Coalition. An estimated 170 were projected to die of the disease.
Earlier this year, Kuster called on the U.S. Department of Health and Human Services (HHS) to cover certain medications that help prevent breast cancer under the Affordable Care Act. HHS issued a ruling that women who are at a higher risk for breast cancer will have access to certain categories of preventative drugs without any out-of-pocket costs.
For more information:

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init